Exosens (LON:0EXO)
London
· Delayed Price · Currency is GBP · Price in EUR | Market Cap | 1.50B |
| Revenue (ttm) | 325.91M |
| Net Income (ttm) | 25.39M |
| Shares Out | n/a |
| EPS (ttm) | n/a |
| PE Ratio | 58.96 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 759,131 |
| Average Volume | 106,529 |
| Open | 33.95 |
| Previous Close | n/a |
| Day's Range | 33.95 - 33.95 |
| 52-Week Range | 14.23 - 18.60 |
| Beta | n/a |
| RSI | 75.64 |
| Earnings Date | Apr 28, 2025 |
About Exosens
Exosens engages in the development, manufacture, and sale of electro-optical technologies in the fields of amplification, and detection and imaging in France, rest of Europe, North America, Asia, Oceania, Africa, and internationally. It offers image intensifier tubes; ultra violet, short and long wave infrared, visible - near infrared, and mid wave infrared cameras, as well as enhanced vision equipment; ion and electron, scintillation, and single photon detection products; x-ray components, neutronic imaging products, and image intensifiers for... [Read more]
Financial Performance
In 2024, Exosens's revenue was 394.10 million, an increase of 35.05% compared to the previous year's 291.82 million. Earnings were 30.70 million, an increase of 317.46%.
Financial numbers in EUR Financial StatementsNews
Exosens: Spectral And Imaging Opportunity With Attractive End Markets
Exosens, a leader in defense and industrial markets, had 35% revenue growth in 2024. It has 22% stock upside and growth-driven potential. Click to read more on EXOSF.